Literature DB >> 25064054

Sulbactam Plays Neuronal Protective Effect Against Brain Ischemia via Upregulating GLT1 in Rats.

Xin Cui1, Li Li, Yu-Yan Hu, Shuang Ren, Min Zhang, Wen-Bin Li.   

Abstract

The study was undertaken to investigate whether sulbactam protects cerebral neurons against ischemia and whether the protection is mediated by regulating the expression and uptake activity of glial glutamate transporter-1 (GLT1) in a rat global brain ischemia model. The CA1 hippocampus was selected as the observing target. Real time quantitative PCR, Western blot and immunohistochemistry assays were used to detect GLT1 expression. Neuropathological evaluation was performed after thionin staining to determine the extent of the delayed neuronal death (DND) of pyramidal neurons. It was found that cerebral ischemia for 8 min induced obvious DND of pyramidal neurons and GLT1 downregulation. Sulbactam pretreatment significantly upregulated GLT1 expression in sham rats and prevented or reversed the GLT1 downregulation normally induced in the ischemic rat brain. Meanwhile, sulbactam pretreatment effectively prevented the DND of pyramidal neurons normally induced by brain ischemia in a dose-dependent manner. Sulbactam posttreatment also protected pyramidal neurons against DND induced by brain ischemia although the magnitude of the protective effect was weaker than that in sulbactam pretreatment. Furthermore, either antisense knockdown of GLT1 expression or inhibition of the GLT1 uptake activity with dihydrokainate, a selective inhibitor of GLT1, significantly blocked the neuronal protective effect of sulbactam. These findings indicate that sulbactam has a neuronal protective effect though upregulating GLT1.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25064054     DOI: 10.1007/s12035-014-8809-3

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  33 in total

1.  Guide to Receptors and Channels (GRAC), 5th edition.

Authors:  Stephen P H Alexander; Alistair Mathie; John A Peters
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

Review 2.  Exciting, radical, suicidal: how brain cells die after stroke.

Authors:  Eng H Lo; Michael A Moskowitz; Thomas P Jacobs
Journal:  Stroke       Date:  2005-01-06       Impact factor: 7.914

Review 3.  [Organ protective effects of volatile anesthetics and perioperative outcomes].

Authors:  Hiroyuki Uchino; Morika Suzuki; Ayano Okita; Yohko Yuhnaiyama; Mariko Shibuya; Daiki Usui; Ryoichi Miyashita; Kiyoshi Hatakeyama
Journal:  Masui       Date:  2012-05

4.  A new model of bilateral hemispheric ischemia in the unanesthetized rat.

Authors:  W A Pulsinelli; J B Brierley
Journal:  Stroke       Date:  1979 May-Jun       Impact factor: 7.914

Review 5.  Glutamate uptake.

Authors:  N C Danbolt
Journal:  Prog Neurobiol       Date:  2001-09       Impact factor: 11.685

6.  Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) Upregulation.

Authors:  Kon Chu; Soon-Tae Lee; Dong-In Sinn; Song-Yi Ko; Eun-Hee Kim; Jeong-Min Kim; Se-Jeong Kim; Dong-Kyu Park; Keun-Hwa Jung; Eun-Cheol Song; Sang Kun Lee; Manho Kim; Jae-Kyu Roh
Journal:  Stroke       Date:  2006-11-22       Impact factor: 7.914

7.  Neuroprotective effect of ceftriaxone on the penumbra in a rat venous ischemia model.

Authors:  T Inui; B Alessandri; A Heimann; F Nishimura; K Frauenknecht; C Sommer; O Kempski
Journal:  Neuroscience       Date:  2013-03-21       Impact factor: 3.590

Review 8.  Determinants of the activity of beta-lactamase inhibitor combinations.

Authors:  D M Livermore
Journal:  J Antimicrob Chemother       Date:  1993-01       Impact factor: 5.790

9.  Ceftriaxone treatment after traumatic brain injury restores expression of the glutamate transporter, GLT-1, reduces regional gliosis, and reduces post-traumatic seizures in the rat.

Authors:  Grant S Goodrich; Anatoli Y Kabakov; Mustafa Q Hameed; Sameer C Dhamne; Paul A Rosenberg; Alexander Rotenberg
Journal:  J Neurotrauma       Date:  2013-07-25       Impact factor: 5.269

10.  Targeted over-expression of glutamate transporter 1 (GLT-1) reduces ischemic brain injury in a rat model of stroke.

Authors:  Brandon K Harvey; Mikko Airavaara; Jason Hinzman; Emily M Wires; Matthew J Chiocco; Douglas B Howard; Hui Shen; Greg Gerhardt; Barry J Hoffer; Yun Wang
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

View more
  11 in total

Review 1.  Are glutamate transporters neuroprotective or neurodegenerative during cerebral ischemia?

Authors:  Li-Nan Zhang; Liang Hao; Yu-Song Guo; Hai-Yan Wang; Lin-Lin Li; Li-Zhe Liu; Wen-Bin Li
Journal:  J Mol Med (Berl)       Date:  2019-01-23       Impact factor: 4.599

2.  Sulbactam improves binding property and uptake capacity of glutamate transporter-1 and decreases glutamate concentration in the CA1 region of hippocampus of global brain ischemic rats.

Authors:  Wei-Wei Gu; Xin Cui; Li-Zhe Liu; Min Zhang; Wen-Bin Li; Xiao-Hui Xian
Journal:  Amino Acids       Date:  2021-10-30       Impact factor: 3.520

3.  GLT-1 Knockdown Inhibits Ceftriaxone-Mediated Improvements on Cognitive Deficits, and GLT-1 and xCT Expression and Activity in APP/PS1 AD Mice.

Authors:  JunXia Gao; LiZhe Liu; Chao Liu; ShuJuan Fan; LiRong Liu; ShuFeng Liu; Xiao-Hui Xian; Wen-Bin Li
Journal:  Front Aging Neurosci       Date:  2020-10-06       Impact factor: 5.750

4.  Immediate inhibition of spinal secretory phospholipase A2 prevents the pain and elevated spinal neuronal hyperexcitability and neuroimmune regulatory genes that develop with nerve root compression.

Authors:  Julia C Quindlen-Hotek; Sonia Kartha; Beth A Winkelstein
Journal:  Neuroreport       Date:  2020-10-14       Impact factor: 1.703

5.  Sulbactam Protects Hippocampal Neurons Against Oxygen-Glucose Deprivation by Up-Regulating Astrocytic GLT-1 via p38 MAPK Signal Pathway.

Authors:  Jie Qi; Xiao-Hui Xian; Li Li; Min Zhang; Yu-Yan Hu; Jing-Ge Zhang; Wen-Bin Li
Journal:  Front Mol Neurosci       Date:  2018-08-15       Impact factor: 5.639

6.  Ampicillin/Sulbactam Treatment Modulates NMDA Receptor NR2B Subunit and Attenuates Neuroinflammation and Alcohol Intake in Male High Alcohol Drinking Rats.

Authors:  Fawaz Alasmari; Hasan Alhaddad; Woonyen Wong; Richard L Bell; Youssef Sari
Journal:  Biomolecules       Date:  2020-07-10

7.  Activation of p38 MAPK participates in the sulbactam-induced cerebral ischemic tolerance mediated by glial glutamate transporter-1 upregulation in rats.

Authors:  Xiao-Hui Xian; Jun-Xia Gao; Jie Qi; Shu-Juan Fan; Min Zhang; Wen-Bin Li
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379

8.  Evaluation of Altered Glutamatergic Activity in a Piglet Model of Hypoxic-Ischemic Brain Damage Using 1H-MRS.

Authors:  Yuxue Dang; Xiaoming Wang
Journal:  Dis Markers       Date:  2020-09-23       Impact factor: 3.434

9.  Isoflurane post-conditioning contributes to anti-apoptotic effect after cerebral ischaemia in rats through the ERK5/MEF2D signaling pathway.

Authors:  Qingtong Zhang; Jiangwen Yin; Feng Xu; Jingwen Zhai; Jieting Yin; Mingyue Ge; Wenyi Zhou; Nian Li; Xinlei Qin; Yan Li; Sheng Wang
Journal:  J Cell Mol Med       Date:  2021-02-23       Impact factor: 5.310

Review 10.  Glial Cells as Therapeutic Approaches in Brain Ischemia-Reperfusion Injury.

Authors:  Ivó H Hernández; Mario Villa-González; Gerardo Martín; Manuel Soto; María José Pérez-Álvarez
Journal:  Cells       Date:  2021-06-30       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.